These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 15197796)

  • 61. Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.
    Lee S; Kim EY; Kang SH; Kim SW; Kim SK; Kang KW; Kwon Y; Shin KH; Kang HS; Ro J; Lee ES
    Breast Cancer Res Treat; 2007 May; 102(3):283-8. PubMed ID: 17063280
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
    Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
    Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy.
    Kinoshita T
    Breast Cancer; 2007; 14(1):10-5. PubMed ID: 17244988
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers.
    Wong SL; Chao C; Edwards MJ; Tuttle TM; Noyes RD; Carlson DJ; Laidley AL; McGlothin TQ; Ley PB; Brown CM; Glaser RL; Pennington RE; Turk PS; Simpson D; McMasters KM
    Am Surg; 2001 Jun; 67(6):522-6; discussion 527-8. PubMed ID: 11409798
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy.
    Javid S; Segara D; Lotfi P; Raza S; Golshan M
    Ann Surg Oncol; 2010 Jul; 17(7):1841-6. PubMed ID: 20143266
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Sentinel lymph node biopsy in breast carcinoma: the experience from the Norwegian Radium Hospital].
    Tafjord S; Qvist H; Bogsrud TV; Reed W
    Tidsskr Nor Laegeforen; 2003 Jun; 123(12):1680-2. PubMed ID: 12821989
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer.
    Hirche C; Murawa D; Mohr Z; Kneif S; Hünerbein M
    Breast Cancer Res Treat; 2010 Jun; 121(2):373-8. PubMed ID: 20140704
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Meta-analysis of sentinel lymph node biopsy in breast cancer.
    Miltenburg DM; Miller C; Karamlou TB; Brunicardi FC
    J Surg Res; 1999 Jun; 84(2):138-42. PubMed ID: 10357910
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques.
    Pelosi E; Bellò M; Giors M; Ala A; Giani R; Bussone R; Bisi G
    J Nucl Med; 2004 Feb; 45(2):220-5. PubMed ID: 14960639
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A prospective feasibility study of sentinel node biopsy by modified Indigocarmine blue dye methods after neoadjuvant chemotherapy for breast cancer.
    Kida K; Ishikawa T; Yamada A; Shimizu D; Tanabe M; Sasaki T; Ichikawa Y; Endo I
    Eur J Surg Oncol; 2015 Apr; 41(4):566-70. PubMed ID: 25650249
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The role of sentinel lymph node biopsy in differentiated thyroid carcinoma.
    Anand SM; Gologan O; Rochon L; Tamilia M; How J; Hier MP; Black MJ; Richardson K; Hakami HA; Marzouki HZ; Trifiro M; Tabah R; Payne RJ
    Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1199-204. PubMed ID: 20026816
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sequential dermal-peritumoral radiocolloid injection for sentinel node biopsy for breast cancer: the University of Florida experience.
    Feezor RJ; Kasraeian A; Copeland EM; Schell SR; Hochwald SN; Cendan J; Drane W; Mastin S; Wilkinson E; Lind DS
    Am Surg; 2002 Aug; 68(8):684-7; discussion 687-8. PubMed ID: 12206602
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Sentinel lymph node biopsy in breast cancer: value for predicting the status of axillary node].
    Su F; Jia W; Li H; Zeng Y; Chen J
    Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):784-6. PubMed ID: 11832165
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers.
    Tousimis E; Van Zee KJ; Fey JV; Hoque LW; Tan LK; Cody HS; Borgen PI; Montgomery LL
    J Am Coll Surg; 2003 Oct; 197(4):529-35. PubMed ID: 14522317
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients.
    van Wessem KJ; Meijer WS
    Breast; 2004 Aug; 13(4):290-6. PubMed ID: 15325663
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Cause of failure and false negative result in sentinel lymph node biopsy through vital blue injection in breast carcinoma].
    Su F; Ba M; Zhou X; Wu X; Li Y; Chen J; Li J
    Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):297-9. PubMed ID: 12515632
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.